Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-29 Option Award |
2024-01-31 4:56 pm |
N/A 2034-01-29 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Interim Chief Medical Officer |
12,500 | $0 | 27,705 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-03 4:55 pm |
2024-06-30 2033-06-30 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
63,657 | $0 | 83,040 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:32 pm |
N/A 2032-06-16 |
INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director |
45,000 | $0 | 75,919 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:32 pm |
N/A N/A |
INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director |
30,919 | $0.679 | 75,919 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:11 pm |
2023-06-14 2032-06-14 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
47,467 | $0 | 51,028 (Direct) |
View |
| 2021-09-07 Option Award |
2021-09-10 12:35 pm |
N/A 2031-09-07 |
INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director |
60,000 | $0 | 60,000 (Direct) |
View |
Ownership |
2021-09-10 12:30 pm |
N/A 2030-05-15 |
INFINITY PHARMACEUTICALS INC. | INFI | SCHWARTZ BRIAN Director |
0 | $0 | 116,250 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 4:07 pm |
2022-06-15 2031-06-15 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
8,309 | $0 | 17,805 (Direct) |
View |
| 2020-12-17 Option Award |
2020-12-21 4:48 pm |
2021-12-17 2030-12-17 |
Cyclacel Pharmaceuticals Inc. | CYCC | SCHWARTZ BRIAN Director |
5,200 | $0 | 5,200 (Direct) |
View |